The treatment history of Lindsay Clancy, the Massachusetts nurse accused of killing her three children, has repeatedly been described as “overmedication.” That description counts prescriptions but does not answer the clinically important question: was she adequately treated for the illness she may actually have had?
A patient can be heavily prescribed yet therapeutically undertreated. She can receive numerous sedatives, starter doses, discontinued antidepressants, and brief medication trials without receiving sustained treatment for bipolar disorder, severe psychotic depression, or postpartum psychosis.
That is the stronger interpretation of the publicly reported record. Clancy received more than 30 prescriptions involving 13 psychiatric medications, but the record does not establish 13 simultaneous medications, two adequate antipsychotic trials, a sustained therapeutic mood-stabilizer regimen, or a coherent psychiatrist-led escalation plan.
This distinction also defines the proper role of nurse practitioners and other midlevel providers. They are most useful when a patient is stable, the diagnosis is established, the medication is working, and no major treatment change is needed. Once deterioration begins, clinical leadership should transfer promptly to a psychiatrist experienced in severe mood and psychotic disorders.
What was actually prescribed
The following is based on the Boston Globe’s timeline compiled from court records:
| Medication | Reported prescription history |
|---|---|
| Sertraline/Zoloft | 25 mg, increased to 50 mg |
| Lorazepam/Ativan | 0.5 mg, increased to 1 mg, later reduced; another 1-mg prescription was subsequently issued |
| Diphenhydramine/Benadryl | 25 mg |
| Buspirone | 5 mg, with a repeated prescription |
| Trazodone | 50 mg; later 150 mg |
| Fluoxetine/Prozac | 10 mg |
| Zolpidem/Ambien | 5 mg |
| Mirtazapine/Remeron | Reported as 5 mg |
| Clonazepam/Klonopin | 0.5 mg |
| Quetiapine/Seroquel | 25 mg, increased to 100 mg and then 300 mg; subsequent prescriptions included 100 mg and 25 mg |
| Diazepam/Valium | Prescriptions at 2, 5, and 10 mg |
| Lamotrigine/Lamictal | 25 mg |
| Amitriptyline | 10 mg, increased to 20 mg |
An earlier WBUR report named hydroxyzine rather than diphenhydramine. Because the published accounts conflict, the underlying prescription records are needed to resolve that detail.
The drugs were prescribed by several types of clinicians: a psychiatrist, psychiatric nurse practitioners or nurse clinicians, an emergency-department physician, and clinicians at McLean Hospital. They were not necessarily taken together. Trial testimony indicated that some bottles contained many unused pills, while Clancy’s former husband testified that some bottles represented prescriptions discontinued after dose changes.
The list therefore proves extensive prescribing—not extensive adequate treatment.
Polypharmacy and undertreatment can coexist
Several medications were prescribed at introductory doses:
Sertraline 25 mg and fluoxetine 10 mg were starting antidepressant doses.
Lamotrigine 25 mg was only the beginning of a required slow titration.
Quetiapine 25 mg was predominantly sedating, not a meaningful antipsychotic dose.
Buspirone 5 mg was low.
Amitriptyline 10–20 mg was low for treatment of major depression.
Other doses were not trivial. Diazepam 10 mg, trazodone 150 mg, and quetiapine 300 mg can produce substantial clinical effects. The argument should therefore not be that every dose was low. The problem was the absence of a sustained, diagnosis-directed strategy.
Trial testimony reportedly established that Clancy took only seven sertraline tablets. A few tablets do not constitute an adequate antidepressant trial. Other antidepressants were also reportedly stopped quickly because of adverse experiences or concern that the medications were worsening her condition. A psychiatric nurse practitioner testified that she advised Clancy that antidepressants could require four to six weeks to work. Boston Globe trial coverage
That advice is generally correct for antidepressants, but it assumes that the diagnosis is unipolar depression and that continuing the drug is safe. A postpartum patient who becomes unable to sleep, develops racing thoughts, feels activated by an antidepressant, or reports unusual perceptual experiences requires immediate reassessment for bipolar disorder or psychosis—not merely encouragement to wait another month.
Not every psychiatric medication needs four weeks. Benzodiazepines and sleep medications work quickly. Antipsychotics can begin reducing agitation, mania, or psychosis within days, although a full therapeutic trial ordinarily requires a sustained adequate dose unless adverse effects make continuation unsafe.
Lamotrigine is especially easy to misinterpret. It must be titrated slowly to reduce the risk of a dangerous rash. A 25-mg prescription was not a therapeutic trial, and lamotrigine is not an emergency treatment for acute mania or psychosis.
Quetiapine 300 mg: meaningful, but possibly inadequate for the suspected illness
Quetiapine 300 mg should not be described as pharmacologically negligible. It is the FDA-labeled dose for bipolar depression and lies within the approved schizophrenia range.
But the appropriate dose depends on the target illness. For acute bipolar mania, the FDA-recommended range is 400–800 mg per day. Bipolar maintenance treatment with lithium or divalproex similarly uses 400–800 mg. If Clancy was developing bipolar mania, a mixed state, or postpartum psychosis, 300 mg may have been only the lower edge of an appropriate antipsychotic strategy—especially if it was not taken consistently or maintained long enough. FDA/DailyMed quetiapine label
The reported timeline shows quetiapine moving from 25 to 100 and then 300 mg, followed by lower prescriptions and discontinuation. Other trial reporting has described an intended daily regimen approaching 400 mg, but the exact administration history remains disputed. The treating psychiatric nurse practitioner testified that Clancy sometimes took less quetiapine than recommended and wanted to discontinue her medications. She also testified that quetiapine helped Clancy sleep but that Clancy felt depressed and fatigued while taking it. CT Insider trial report
Quetiapine doses of 900–1,200 mg are sometimes used off-label in treatment-resistant cases. They exceed the FDA-labeled maximum of 750–800 mg and require specialist judgment and monitoring. Randomized trials comparing 1,200 mg with 600 or 800 mg did not establish superior average efficacy. 600 versus 1,200 mg trial 800 versus 1,200 mg trial
The central criticism is not that every patient with psychosis should receive 1,200 mg of quetiapine. It is that a deteriorating patient should receive a sustained trial within an appropriate therapeutic range, with adherence established and response measured. If an adequate trial fails, the psychiatrist should move decisively to another antipsychotic, lithium, ECT, or eventually clozapine rather than cycling through more sedatives and introductory doses.
Midlevel providers are best suited to stable maintenance care
Nurse practitioners and physician assistants can provide useful and efficient care when:
The diagnosis is established.
The patient is clinically stable.
The current medication is effective.
No substantial treatment change is required.
Laboratory and adverse-effect monitoring follow a defined protocol.
A psychiatrist is available when deterioration occurs.
In this setting, midlevel providers can renew medications, reinforce adherence, obtain routine monitoring, screen for adverse effects, and identify early warning signs.
Unstable psychiatric illness is fundamentally different. Diagnostic uncertainty and treatment resistance require experience acquired through repeated supervised exposure to mania, psychosis, catatonia, severe depression, neurological mimics, medication toxicity, involuntary hospitalization, ECT, lithium, and clozapine.
Psychiatrists complete medical school followed by a four-year psychiatry residency. Psychiatric nurse practitioners follow a different and generally shorter required clinical pathway, and postgraduate NP residencies are not universally mandatory. AAMC physician-training overview AANP position on mandatory NP residencies
The difference should not be treated as an insult. It should determine scope of responsibility.
A recurrent danger among less-experienced prescribers is therapeutic timidity: remaining at starter doses, using sedatives instead of treating the underlying illness, discontinuing drugs before an adequate trial, hesitating to reach therapeutic antipsychotic doses, and delaying hospitalization or specialist escalation.
Paradoxically, therapeutic timidity can produce polypharmacy. Instead of decisively treating the suspected disorder, the clinician adds one low-dose drug for sleep, another for anxiety, another for depression, and another for adverse effects. The patient accumulates prescriptions without receiving an adequate trial of the treatment most likely to control the core illness.
This does not describe every nurse practitioner, and physicians can make precisely the same errors. The Clancy record also does not support blaming midlevel providers alone. A psychiatrist prescribed several medications, while one nurse practitioner reportedly considered bipolar disorder and strongly recommended partial hospitalization. The patient and her husband reportedly questioned the bipolar formulation, and Clancy was fearful of medication changes.
The point is institutional: once serious deterioration appears, escalation to specialist leadership must be mandatory rather than dependent on whether an individual midlevel clinician feels comfortable continuing the case.
Mandatory triggers for psychiatrist takeover
A midlevel provider should not remain the final clinical authority when any of the following develops:
Possible mania, mixed symptoms, or psychosis
Forty-eight hours without sleep, particularly without normal fatigue
Racing thoughts or marked antidepressant activation
Hallucinations, delusions, confusion, or impaired reality testing
Persistent suicidal thoughts
Thoughts or urges involving harm to a child
A request not to be left alone because the patient fears what might happen
Rapid functional deterioration
Repeated emergency calls or visits
Failure of an initial treatment strategy
Multiple major medication changes within a short period
Uncertain adherence or rapidly changing doses
Diagnostic disagreement between clinicians
Need for lithium, ECT, high-dose antipsychotic treatment, or clozapine consideration
The psychiatrist should review the complete record, contact prior prescribers, obtain collateral information from family, reconstruct what was actually taken, and create a written treatment hierarchy. In a dangerous postpartum case, this assessment will frequently require hospitalization.
In Clancy’s case, testimony indicated that the psychiatric nurse practitioner and psychiatrist treating her during overlapping periods did not communicate with each other. The nurse practitioner reportedly did not obtain records from the psychiatrist, Women & Infants Hospital, or McLean Hospital. The psychiatrist also reportedly lacked portions of the emergency-treatment record. ABC News trial coverage
Fragmented care is especially hazardous when every clinician sees only a small portion of a rapidly changing psychiatric illness.
Dangerous thoughts require eyesight supervision
Trial testimony indicated that Clancy told her mother and then-husband that she had thoughts about harming the children. Her mother also described messages in which Clancy said that she was seriously ill, that something was wrong, and that she did not want to be alone. Guardian trial report
Other testimony indicated that she did not disclose thoughts of harming the children to medical providers who asked her. The record therefore should not be rewritten to claim that every treating clinician knew she had homicidal intent. It does establish that dangerous thoughts were disclosed within the family and that she reportedly expressed fear of being alone.
There is an important clinical distinction between an unwanted, ego-dystonic intrusive thought and an urge, intention, delusion, or command hallucination. Postpartum obsessive-compulsive symptoms can include horrifying thoughts that the mother does not want and is unlikely to act upon. But when harm thoughts occur alongside suicidality, severe insomnia, rapid deterioration, possible bipolar illness, impaired judgment, or psychotic symptoms, they must be treated as potentially dangerous until a specialist completes the assessment.
The immediate response should be continuous direct eyesight supervision—not occasional telephone calls, electronic messages, visits every few hours, or merely having another adult somewhere in the house.
Eyesight supervision means:
One responsible adult has no competing duty and continuously keeps the patient within direct visual observation.
The mother is never left alone with the children.
Responsibility is formally handed from one observer to the next, without gaps.
Medications, weapons, ligatures, vehicle keys, and other potentially dangerous objects are secured.
The observer is close enough to intervene immediately.
Any escalation, disappearance from view, command hallucination, plan, or attempt triggers emergency intervention.
The arrangement continues during transportation and while awaiting transfer to a secure treatment setting.
The Joint Commission requires constant one-to-one visual observation for hospital patients at high suicide risk when environmental dangers are present. The observer must be assigned to that one patient and able to intervene immediately; video monitoring alone is generally insufficient. Joint Commission guidance
The same practical principle applies when a severely ill parent may pose an immediate danger to children. A person cannot complete a lethal act that another alert adult sees beginning and physically interrupts. Eyesight supervision creates the opportunity for immediate intervention that periodic checks do not.
It is not a substitute for treatment, and it is not infallible. An exhausted or distracted family member is not equivalent to trained one-to-one observation. When the risk is immediate, uncertain, or more than a family can reliably manage, supervision at home should serve only as a bridge to emergency evaluation and hospitalization.
The key error is treating the absence of a declared plan as proof of safety. A psychotic, impulsive, severely depressed, or mixed-state patient may act with little warning. Protective action should begin when the combination of symptoms and disclosures creates a credible possibility of danger—not only after the patient provides a time, place, and method.
Bipolar disorder had to be addressed directly
It is inaccurate to claim that most postpartum depression is bipolar disorder. A major study nevertheless found bipolar disorder in 22.6% of postpartum women who screened positive for depression—approximately one in five. Wisner and colleagues
That proportion is too large to ignore. ACOG recommends screening for bipolar disorder before beginning pharmacological treatment for perinatal depression or anxiety, because antidepressant monotherapy can precipitate mania, mixed symptoms, agitation, or cycling in susceptible patients. ACOG perinatal mental-health guidance
Clancy reportedly experienced severe insomnia, racing thoughts, emotional blunting, suicidal thinking, repeated medication intolerance, and possible auditory experiences. One treating nurse practitioner testified that she considered bipolar disorder because Clancy had remained awake for 48 hours after taking an antidepressant. Defense experts at trial subsequently diagnosed bipolar disorder and postpartum psychosis. A prosecution psychiatrist disagreed, diagnosing a major depressive episode without mania or psychosis. Summary of the competing expert opinions
The diagnosis is therefore contested. But that dispute reinforces the need for senior specialist care. When the differential diagnosis includes unipolar depression, bipolar disorder, postpartum psychosis, medication activation, obsessive intrusive thoughts, and medical causes, repeated outpatient medication adjustments by disconnected providers are inadequate.
What diagnosis-directed treatment might have looked like
If the working diagnosis were ordinary unipolar depression with anxiety and insomnia, an adequate antidepressant trial with careful monitoring might have been reasonable.
If the working diagnosis shifted to bipolar disorder, a mixed state, or postpartum psychosis, treatment priorities would change:
Stop or reconsider antidepressants that appeared activating.
Hospitalize when safety or diagnostic clarity could not be assured.
Institute constant eyesight supervision while hospitalization was arranged.
Prohibit unsupervised childcare until the patient was demonstrably stable.
Use an antipsychotic at a therapeutic dose for a sufficient period.
Consider lithium promptly unless contraindicated.
Obtain serum drug levels when response was inadequate or adherence uncertain.
Use ECT when rapid control was needed or medication failed.
Establish a predetermined pathway to another antipsychotic and eventually clozapine if adequate trials failed.
Postpartum psychosis is usually treated as a psychiatric emergency. Contemporary reviews emphasize hospitalization, lithium, second-generation antipsychotics, benzodiazepines when appropriate, and ECT. Psychiatric Times clinical review
A sequential-treatment study involving benzodiazepines, antipsychotics, and lithium reported remission in 98.4% of patients with postpartum psychosis. Lithium provided better relapse prevention than antipsychotic monotherapy. Postpartum psychosis treatment study
The absence of a sustained lithium-centered or comparable mood-stabilizing strategy is more clinically important than the raw number of prescriptions.
Clozapine should have been on the escalation map
Clozapine has shown benefit in treatment-resistant bipolar illness. A systematic review reported improvements in mania, depression, psychosis, rapid cycling, hospitalization, aggression, self-harm, and suicidality, while acknowledging that the evidence was less definitive than in schizophrenia. Systematic review
For a severely ill patient who remains manic or psychotic after two adequate antipsychotic or mood-stabilizing strategies, clozapine should be part of the documented specialist discussion. It should not be postponed indefinitely simply because it requires blood monitoring and more intensive management.
The reported Clancy history does not establish two adequate antipsychotic failures. Quetiapine was the only clearly documented antipsychotic, and its dose changed repeatedly before discontinuation. That does not make clozapine irrelevant. It illustrates that her care apparently never progressed through an orderly treatment-resistance algorithm capable of reaching a reasoned clozapine decision.
The failure may not have been refusal to prescribe clozapine itself. It may have been failure to create the structured pathway that would have led to lithium, a second adequate antipsychotic trial, ECT, and then clozapine if necessary.
The patient and family needed an unmistakable warning
Clancy was a labor-and-delivery nurse. A psychiatrist could have explained the suspected diagnosis, treatment alternatives, and danger in direct technical language. But every patient and family deserves the same essential candor.
A suitable warning would be:
“This may be bipolar disorder or postpartum psychosis rather than ordinary anxiety or depression. Because you have experienced thoughts involving harm to yourself or the children, you cannot be left alone or be the children’s sole caregiver. A responsible adult must keep you continuously within eyesight until you are evaluated and stabilized. If that cannot be guaranteed, you need hospitalization.”
This is not an accusation that the mother intends to kill anyone. It is a temporary medical safety restriction, comparable to prohibiting driving during uncontrolled seizures.
News reports of mothers who harmed their children should not substitute for individual risk assessment or be used to shame a patient. They do demonstrate why clinicians must be blunt about the stakes. Professional status, intelligence, insight during an office interview, and love for one’s children do not eliminate the risks of rapidly worsening psychosis or mania.
The central lesson
No retrospective analysis can establish that one particular medication or safety intervention would certainly have prevented this tragedy. The criminal and civil proceedings must determine disputed facts, diagnoses, responsibility, and causation from the complete record.
But the policy lesson is already visible.
The number of prescriptions is the wrong measure of treatment intensity. Clancy may have been heavily prescribed while remaining undertreated for the severe illness her defense experts say she had. Multiple starter doses and sedatives cannot substitute for a sustained therapeutic antipsychotic regimen, a genuine mood stabilizer, hospitalization, ECT, or a structured path toward clozapine.
Nor can periodic contact substitute for direct observation when dangerous thoughts, severe deterioration, and possible psychosis converge. Continuous eyesight supervision provides something that prescriptions and telephone check-ins cannot: an alert person who can see a dangerous act beginning and intervene immediately.
Midlevel providers have an important place in psychiatric care, but their best role is maintaining patients who are doing well and need no material treatment change. They should not independently carry a rapidly deteriorating postpartum patient through repeated medication failures and diagnostic uncertainty.
Once deterioration begins, specialist care is not an optional consultation. The psychiatrist must take command of diagnosis, medication selection, therapeutic dosing, hospitalization decisions, family warnings, continuous-supervision requirements, and the escalation pathway.
Stable maintenance belongs comfortably within midlevel care. Severe deterioration belongs under specialist leadership—and credible danger requires uninterrupted eyesight supervision until safety is restored.
No comments:
Post a Comment